Type 1 segmental Darier disease unmasked by enfortumab vedotin
Nina B Curkovic, Yash Kumar, Sheba Jaison Joy, Tian Zhang, Travis Vandergriff, Meghan Heberton · 2026
Read Type 1 segmental Darier disease unmasked by enfortumab vedotin by Nina B Curkovic, Yash Kumar, Sheba Jaison Joy, Tian Zhang, Travis Vandergriff, Meghan Heberton (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13635490.txt.
Description
Nina Curkovic and co-authors report a skin disease unmasked by a cancer drug, in a 2026 case report. Darier disease is a rare inherited skin condition that usually appears in the teen years as rough, red-brown bumps in oily skin areas. In its segmental form it strikes only one body region, because the gene fault sits in just part of the skin.
Their patient's hidden segmental disease flared after treatment with enfortumab vedotin, an antibody-drug used against bladder cancer. The case walks through the signs that separated this flare from other drug rashes, including the telltale nail changes of Darier disease. Knowing that a cancer drug can wake a silent gene fault helps teams name odd rashes fast and treat them right.
Catalog record
| CREATOR | Nina B Curkovic, Yash Kumar, Sheba Jaison Joy, Tian Zhang, Travis Vandergriff, Meghan Heberton |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |